中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
27期
321-322
,共2页
稳心颗粒%心力衰竭%短阵室速
穩心顆粒%心力衰竭%短陣室速
은심과립%심력쇠갈%단진실속
Wenxinkeli%Heart failure%Paroxysmal ventricular tachycardia
目的:对比观察稳心颗粒治疗心力衰竭伴室速的疗效。方法选取慢性心力衰竭伴短阵室速的患者69例,随机分为治疗组35例,对照组34例。治疗组给予原发病及常规抗心衰治疗药物基础上,给稳心颗粒口服。9g/次,3次/天;对照组给予原发病及常规抗心衰治疗。随时心电图及4周后动态心电图观察疗效。结果稳心颗粒对短阵室速的总有效率为97.1%,对照组总有效率为79.4%,两组治疗效果差异有显著性(P<0.05),治疗组明显优于对照组,且不良反应少,不使心衰患者症状加重。结论稳心颗粒对慢性心力衰竭伴短阵室速患者的室速有良好疗效,且不良反应少,不使心衰患者症状加重。
目的:對比觀察穩心顆粒治療心力衰竭伴室速的療效。方法選取慢性心力衰竭伴短陣室速的患者69例,隨機分為治療組35例,對照組34例。治療組給予原髮病及常規抗心衰治療藥物基礎上,給穩心顆粒口服。9g/次,3次/天;對照組給予原髮病及常規抗心衰治療。隨時心電圖及4週後動態心電圖觀察療效。結果穩心顆粒對短陣室速的總有效率為97.1%,對照組總有效率為79.4%,兩組治療效果差異有顯著性(P<0.05),治療組明顯優于對照組,且不良反應少,不使心衰患者癥狀加重。結論穩心顆粒對慢性心力衰竭伴短陣室速患者的室速有良好療效,且不良反應少,不使心衰患者癥狀加重。
목적:대비관찰은심과립치료심력쇠갈반실속적료효。방법선취만성심력쇠갈반단진실속적환자69례,수궤분위치료조35례,대조조34례。치료조급여원발병급상규항심쇠치료약물기출상,급은심과립구복。9g/차,3차/천;대조조급여원발병급상규항심쇠치료。수시심전도급4주후동태심전도관찰료효。결과은심과립대단진실속적총유효솔위97.1%,대조조총유효솔위79.4%,량조치료효과차이유현저성(P<0.05),치료조명현우우대조조,차불량반응소,불사심쇠환자증상가중。결론은심과립대만성심력쇠갈반단진실속환자적실속유량호료효,차불량반응소,불사심쇠환자증상가중。
Objective To compare the curative effect of Wenxin Granule in the treatment of heart failure and ventricular tachycardia. Methods To select 69 patients of chronic heart failure with nonsustained ventricular tachycardia, randomly divided into treatment group 35 cases, control group 34 cases. The treatment group was given primary diseases and routine anti-heart failure drugs basis, to Wenxinkeli orally. 9 grams each time, 3 times/day;the control group was given conventional therapy of primary disease and. At any time the ECG and dynamic ECG curative effect observation after 4 weeks. Results Wenxin Granule on paroxysmal ventricular tachycardia and the total effective rate was 97.1%, total effective rate of the control group was 79.4%, there was significant difference between the therapeutic effect of two groups (P<0.05), the treatment group was significantly better than the control group, and less adverse reactions, not the symptoms of patients with severe heart failure. Conclusion Wenxin particle velocity has a good therapeutic effect on chronic heart failure patients with paroxysmal ventricular tachycardia ventricular, and less adverse reactions, not the symptoms of patients with sev.